机构:[1]The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Province Hospital of Chinese Medicine, Guangzhou, Guangdong Province, P.R. China广东省中医院[2]The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province, P.R. China广东省中医院
This work was supported by the 13th Zhaoyang Talent Plan of Guangdong Province
Hospital of Chinese Medicine (No. ZY2022YL11) and Special project of Guangdong
Province Hospital of Chinese Medicine (No. YN2020QN06).
语种:
外文
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2022]版:
大类|3 区医学
小类|4 区神经科学
最新[2025]版:
无
第一作者:
第一作者机构:[1]The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Province Hospital of Chinese Medicine, Guangzhou, Guangdong Province, P.R. China[2]The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province, P.R. China
通讯作者:
通讯机构:[1]The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Province Hospital of Chinese Medicine, Guangzhou, Guangdong Province, P.R. China[2]The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province, P.R. China
推荐引用方式(GB/T 7714):
Tan Qijia,Lu Jiamin,Liang Jingtong,et al.A review of traditional Chinese medicine Curcumae Rhizoma for treatment of glioma[J].NANOWIRED DELIVERY OF DRUGS AND ANTIBODIES FOR NEUROPROTECTION IN BRAIN DISEASES WITH CO-MORBIDITY FACTORS, PT B.2023,172:303-319.doi:10.1016/bs.irn.2023.07.004.
APA:
Tan Qijia,Lu Jiamin,Liang Jingtong,Zhou Yuchen,Yang Chunrong...&Li Cong.(2023).A review of traditional Chinese medicine Curcumae Rhizoma for treatment of glioma.NANOWIRED DELIVERY OF DRUGS AND ANTIBODIES FOR NEUROPROTECTION IN BRAIN DISEASES WITH CO-MORBIDITY FACTORS, PT B,172,
MLA:
Tan Qijia,et al."A review of traditional Chinese medicine Curcumae Rhizoma for treatment of glioma".NANOWIRED DELIVERY OF DRUGS AND ANTIBODIES FOR NEUROPROTECTION IN BRAIN DISEASES WITH CO-MORBIDITY FACTORS, PT B 172.(2023):303-319